Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model

Respiratory syncytial virus (RSV) is the cause of significant morbidity and mortality among infants, and despite decades of research there remains no licensed vaccine. SeVRSV is a Sendai virus (SeV)-based live intranasal vaccine that expresses the full length RSV fusion (F) gene. SeV is the murine c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jones, Bart G., Sealy, Robert E., Surman, Sherri L., Portner, Allen, Russell, Charles J., Slobod, Karen S., Dormitzer, Philip. R., DeVincenzo, John, Hurwitz, Julia L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4049121/
https://ncbi.nlm.nih.gov/pubmed/24721531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.03.088
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados